OPIANT PHARMACEUTICALS, INC. Annual Return On Equity in % from 2012 to 2021

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Opiant Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2021.
  • Opiant Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2022 was -97.2 %, a 2386% decline year-over-year.
  • Opiant Pharmaceuticals, Inc. annual Return On Equity for 2021 was 7.56 %.
  • Opiant Pharmaceuticals, Inc. annual Return On Equity for 2020 was -5.35 %, a 112% decline from 2019.
  • Opiant Pharmaceuticals, Inc. annual Return On Equity for 2019 was 45.1 %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2021 7.56 +12.9 Jan 1, 2021 Dec 31, 2021
2020 -5.35 -50.4 -112% Jan 1, 2020 Dec 31, 2020
2019 45.1 +196 Jan 1, 2019 Dec 31, 2019
2018 -150 -102 -213% Jan 1, 2018 Dec 31, 2018
2017 -48.1 -187 -135% Jan 1, 2017 Dec 31, 2017
2016 139 +25.5 +22.5% Aug 1, 2015 Jul 31, 2016
2015 113 -404 -78.1% Aug 1, 2014 Jul 31, 2015
2014 517 -568 -52.3% Aug 1, 2013 Jul 31, 2014
2013 1.09K -1.96K -64.4% Aug 1, 2012 Jul 31, 2013
2012 3.05K Aug 1, 2011 Jul 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.